News Conference News AHA 2015 AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More Shelley Wood November 05, 2015
News Daily News Study Suggests Nonculprit Revascularization Enhances Health Status of STEMI Patients Todd Neale November 04, 2015
News Industry News Neuravi Announces First Patient Treated in International Pivotal Clinical Trial of Novel Stent Retriever for Acute Ischemic Stroke November 04, 2015
News Daily News Endovascular Therapy Beats Thrombolysis for Improving Function After Stroke L.A. McKeown November 03, 2015
News Daily News Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis L.A. McKeown November 01, 2015
News Features Interventionalist vs Neurologist: RESPECT for Both Sides of the PFO Closure Debate Yael L. Maxwell November 01, 2015
News Daily News Door Closing on Low-fat Diets for Long-term Weight Management Todd Neale November 01, 2015
News Daily News Morphine’s Worrisome Effects on Ticagrelor Affirmed in Pharmacokinetic Study Shelley Wood October 29, 2015
News Daily News Early Invasive Approach After Cardiac Arrest Gains Support Todd Neale October 28, 2015
News Daily News More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions L.A. McKeown October 26, 2015
News Daily News Guideline Update Boosts Nonculprit PCI, Knocks Down Aspiration Thrombectomy Todd Neale October 26, 2015
News Daily News Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES Yael L. Maxwell October 26, 2015
News Daily News First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions Todd Neale October 26, 2015
News Industry News Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II Clinical Trial for Heart Failure October 22, 2015
News Industry News One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015 October 20, 2015
News Industry News First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations October 20, 2015
News Industry News FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa October 20, 2015
Presentation TCT 2015 First-in-Man Experience With Human Embryonic Stem Cell-Derived Progenitors for Heart Failure Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Philippe Menasché October 15, 2015